| [1] |
Dukhovny S, Wikins-Hang L, Shipp TD, et al. Absent fetal nasal bone: what does it mean for the euploid fetus?[J]. Utrasound Med, 2013, 32(12): 2131-2134.
|
| [2] |
吴桂花，蔡海云，刘亚军，等．孕15～20＋6周产前超声筛查联合孕妇血清学筛查提高胎儿染色体异常检出率的临床研究[J/ CD]. 中华医学超声杂志(电子版), 2014, 11(10): 828-831.
|
| [3] |
谢红宁，朱云晓，李丽娟，等．胎儿鼻骨超声测量对染色体异常的诊断价值[J]. 中华围产医学杂志，2006, 9(2): 89-92.
|
| [4] |
李胜利，罗国阳. 胎儿畸形产前超声诊断学[M]. 2版. 北京：科学出版社，2017：87.
|
| [5] |
李玮璟，闫瑞玲，张永良，等. 妊娠早期超声多指标筛查胎儿染色体异常的临床价值[J]. 中华围产医学杂志，2013, 16(2): 82-85.
|
| [6] |
Hung JH, Fu CY, Chen CY, et al. Fetal nasal bone length and Down syndrome during the second trimester in a Chinese population[J]. J Obstet Gynaecol Res, 2008, 34(4): 518-523.
|
| [7] |
Bethune M. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone[J]. Australas Radiol, 2007, 51(3): 218-225.
|
| [8] |
Ting YH, Lao TT, Lau TK, et al. Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary？[J]. J Matern Fetal Neonatal Med, 2011, 24(4): 555-558.
|
| [9] |
侯磊，王小新，姜海利，等. 鼻骨发育异常胎儿产前诊断结果的分析[J]. 中华医学杂志，2018，98(43): 3532-3535.
|
| [10] |
Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5 000 pregnancies[J]. Prenat Diagn, 2012, 32(10): 976-985.
|
| [11] |
Shaffer LG, Dosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomic alteration by microarray analysis for specific anomalies detected by ultrasound[J]. Prenat Diagn, 2012, 32(10): 986-995.
|
| [12] |
李茹，邓琼，廖灿，等. 染色体微阵列技术在超声异常胎儿预后评估中的应用[J]．实用妇产科杂志，2018，34(11)：803-806.
|
| [13] |
杨昕，韩瑾，甄理，等．胎儿鼻骨缺失或发育不良与染色体核型异常的关系——187例分析[J]．中华围产医学，2015, 18(5): 339-342.
|
| [14] |
刘宇，范燕洁，叶荟，等. 通过1例22号染色体三体嵌合探讨无创产前检测异常结果的后续诊断策略[J]. 中华检验医学杂志，2017，40(7): 495-499.
|
| [15] |
Committee on Practice Bulletins--Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine. Practice bulletin No. 163: screening for fetal aneuploidy[J]. Obstet Gynecol, 2016, 127(5): e123-e137.
|
| [16] |
张艳亮，戴永，涂植光，等. 微阵列比较基因组杂交产前诊断8p23.1重复综合征胎儿的实验研究[J]. 第三军医大学学报，2009，31(17): 1700-1701.
|
| [17] |
陈万金，王丹妮，何瑾，等. 应用多重连接依耐性探针扩增技术快速诊断遗传性压力敏感性周围神经病[J]. 中华神经科杂志，2015，48(1)：23-27.
|
| [18] |
Jaiswal SK, Kumar A, Ali A, et al. Co-occurrence of mosaic supernumerary isochromosome 18p and intermittent 2q13 deletions in a child with multiple congenital anomalies[J]. Gene, 2015, 559(1): 94-98.
|
| [19] |
秦朗，赵福敏，陈娇，等. 产前经腹胎儿超声诊断体外受精-胚胎移植胎儿鼻骨发育异常的临床价值[J/CD]. 中华妇幼临床医学杂志(电子版)，2019, 15(4): 389-395.
|
| [20] |
Macferran KM, Buchmann RF, Ramakrishnaiah R, et al. Pontine tegmental cap dysplasia with a 2q13 microdeletion involving the NPHP1 gene: insights into malformations of the mid-hindbrain[J]. Semin Pediatr Neurol, 2010, 17(1): 69-74.
|
| [21] |
Hou L, Wang XX, Jiang HL, et al. Article in Chinese; Abstract available in Chinese from the publisher[J]. Chin Med J, 2018, 98(43): 3532-3535.
|
| [22] |
Du Y, Ren Y, Yan Y, et al. Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women[J]. Acta Obstet Gynecol Scand, 2018, 97(2): 180-186.
|
| [23] |
Poureisa M, Daghighi MH, Mazaheri Khameneh R, et al. Fetal nasal bone status in Iranian women undergoing first-trimester screening for trisomy 21: a review and an observational study[J]. Iran J Radiol, 2015, 12(4): e11905.
|
| [24] |
Papasozomenou P, Athanasiadis AP, Zafrakas M, et al.Three-dimensional versus two-dimensional ultrasound for fetal nasal bone evaluation in the second trimester[J]. J Matern Fetal Neonatal Med, 2015, 28(12): 1432-1437.
|
| [25] |
Lee W, DeVore GR, Comstock CH, et al. Nasal bone evaluation in fetuses with Down syndrome during the second and third trimesters of pregnancy[J]. J Ultrasound Med, 2003, 22(1): 55-60.
|
| [26] |
Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study[J]. Lancet, 2001, 358(9294): 1665-1667.
|
| [27] |
Tuxen A, Keeling JW, Reintoft I, et al. A histological and radiological investigation of the nasal bone in fetuses with Down syndrome[J]. Ultrasound Obstet Gynecol, 2003, 22(1): 22-26.
|
| [28] |
Hagen A, Albig M, Keller T, et al. Suspicious prenasal skin thickness-to-nasal bone length ratio: prevalence and correlation with other markers in second and third trimester fetuses with down syndrome[J]. Ultraschall Med, 2015, 36(5): 501-506.
|
| [29] |
Cicero S, Spencer K, Avgidou K, et al. Maternal serum biochemistry at 11-13＋6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening[J]. Prenat Diagn, 2005, 25(11): 977-983.
|
| [30] |
Zoppi MA, Ibba RM, Axiana C, et al. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency, screening in unselected pregnancies[J]. Prenat Diagn, 2003, 23(6): 496-500.
|
| [31] |
Geipel A, Willruth A, Vieten J, et al. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester[J]. Ultrasound Obstet Gynecol, 2010, 35(5): 535-539.
|
| [32] |
Benoit B, Chaoui R. Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in second-trimester screening for Down syndrome[J]. Ultrasound Obstet Gynecol, 2005, 25(1): 19-24.
|
| [33] |
Cicero S, Bindra R, Rembouskos G, et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks[J]. Prenat Diagn, 2003, 23(4): 306-310.
|